Multicancer detection tests: What we know and what we don't know
- PMID: 38517471
- DOI: 10.3322/caac.21836
Multicancer detection tests: What we know and what we don't know
Comment on
-
Cancer screening with multicancer detection tests: A translational science review.CA Cancer J Clin. 2024 Jul-Aug;74(4):368-382. doi: 10.3322/caac.21833. Epub 2024 Mar 22. CA Cancer J Clin. 2024. PMID: 38517462 Free PMC article. Review.
References
REFERENCES
-
- Rubinstein WS, Patriotis C, Dickherber A, et al. Cancer screening with multicancer detection tests: a translational science review. CA Cancer J Clin. 2024. doi:10.3322/caac.21833
-
- Guerra CE, Sharma PV, Castillo BS. Multi‐cancer early detection: the new frontier in cancer early detection. Annu Rev Med. 2024;75(1):67‐81. doi:10.1146/annurev‐med‐050522‐033624
-
- Siegel RL, Giaquinto AN, Jemal A. Cancer statistics 2024. CA Cancer J Clin. 2024;74(1):12‐49. doi:10.3322/caac.21820
-
- Schrag D, Beer TM, McDonnell CH 3rd, et al. Blood‐based tests for multicancer early detection (PATHFINDER): a prospective cohort study. Lancet. 2023;402(10409):1251‐1260. doi:10.1016/s0140‐6736(23)01700‐2
-
- Placido D, Yuan B, Hjaltelin JX, et al. A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. Nat Med. 2023;29(5):1113‐1122. doi:10.1038/s41591‐023‐02332‐5
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical